Breaking News

Genmab Sells Manufacturing Facility to Baxter

Baxter acquires facility, land, and equipment in Brooklyn Park, MN

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Genmab has signed an agreement with Baxter Healthcare Corp. for the sale of its non-plasma-derived antibody manufacturing facility in Brooklyn Park, MN, for $10 million. Baxter acquires the facility, land, and equipment at the site, and will offer employment to the 23 employees currently supporting the facility.   “We have delivered on our commitment to execute the sale of the antibody manufacturing facility in the first quarter of this year and are very pleased that Baxter acquired the fa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters